Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-01
DOI
10.1038/s41401-019-0281-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-Targeted Chemoimmunotherapy with Immune-Checkpoint Blockade for Enhanced Anti-Melanoma Efficacy
- (2019) Man Li et al. AAPS Journal
- Tumor Microenvironmental pH and Enzyme Dual Responsive Polymer-Liposomes for Synergistic Treatment of Cancer Immuno-Chemotherapy
- (2019) Ya Liu et al. BIOMACROMOLECULES
- STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes
- (2019) Morten Nørgaard Andersen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A new immune-nanoplatform for promoting adaptive antitumor immune response
- (2019) María Merino et al. Nanomedicine-Nanotechnology Biology and Medicine
- Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
- (2019) Fangyuan Zhou et al. ADVANCED MATERIALS
- Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy
- (2018) Arunkumar Pitchaimani et al. BIOMATERIALS
- Liposomal nanohybrid cerasomes targeted to PD-L1 enable dual-modality imaging and improve antitumor treatments
- (2018) Yang Du et al. CANCER LETTERS
- Therapeutic Targeting of Tumor-Associated Macrophages in Pancreatic Neuroendocrine Tumors
- (2018) Sebastian Krug et al. INTERNATIONAL JOURNAL OF CANCER
- Reversal of indoleamine 2,3-dioxygenase–mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
- (2018) Todd A Triplett et al. NATURE BIOTECHNOLOGY
- Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity
- (2018) Yuan Zhang et al. Nature Communications
- Induction of enhanced immunogenic cell death through ultrasound-controlled release of doxorubicin by liposome-microbubble complexes
- (2018) Feng-Ying Huang et al. OncoImmunology
- Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment
- (2018) Bing Feng et al. ADVANCED MATERIALS
- Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity
- (2018) Zili Gu et al. JOURNAL OF CONTROLLED RELEASE
- Personalized Tumor RNA Loaded Lipid-Nanoparticles Prime the Systemic and Intratumoral Milieu for Response to Cancer Immunotherapy
- (2018) Elias J. Sayour et al. NANO LETTERS
- Self-Supplied Tumor Oxygenation through Separated Liposomal Delivery of H2O2 and Catalase for Enhanced Radio-Immunotherapy of Cancer
- (2018) Xuejiao Song et al. NANO LETTERS
- EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer
- (2018) Yuan Li et al. Nanoscale
- Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
- (2018) Jianqin Lu et al. ACS Nano
- RNA-Based Immunostimulatory Liposomal Spherical Nucleic Acids as Potent TLR7/8 Modulators
- (2018) Chenxia Guan et al. Small
- Strong adhesion by regulatory T cells induces dendritic cell cytoskeletal polarization and contact-dependent lethargy
- (2017) Jiahuan Chen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- De-novo and acquired resistance to immune checkpoint targeting
- (2017) Nicholas L Syn et al. LANCET ONCOLOGY
- Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses
- (2017) Boning Liu et al. mAbs
- Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression
- (2017) Canan Kasikara et al. MOLECULAR CANCER RESEARCH
- Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers
- (2017) Elizabeth L. Siegler et al. MOLECULAR THERAPY
- Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
- (2017) Yuchen Fan et al. NANO LETTERS
- Reprogramming Tumor-Associated Macrophages To Reverse EGFRT790M Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat
- (2017) Huige Peng et al. NANO LETTERS
- Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: In vitro and in vivo studies
- (2017) Amin Reza Nikpoor et al. Nanomedicine-Nanotechnology Biology and Medicine
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode
- (2017) A. Vlahopoulos Spiros Cancer Biology & Medicine
- Intracellularly Acid-Switchable Multifunctional Micelles for Combinational Photo/Chemotherapy of the Drug-Resistant Tumor
- (2016) Tingting Wang et al. ACS Nano
- Super natural killer cells that target metastases in the tumor draining lymph nodes
- (2016) Siddarth Chandrasekaran et al. BIOMATERIALS
- Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach
- (2016) Yao Lu et al. CANCER LETTERS
- Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer
- (2016) Heidi Griesmann et al. GUT
- Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles
- (2016) Eleni Maria Varypataki et al. JOURNAL OF CONTROLLED RELEASE
- Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy
- (2016) Dangge Wang et al. NANO LETTERS
- Drugs acting on homeostasis: challenging cancer cell adaptation
- (2015) Maria Moschovi et al. Expert Review of Anticancer Therapy
- Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model
- (2015) Oleg V. Markov et al. JOURNAL OF CONTROLLED RELEASE
- Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma
- (2015) Takashi Nakamura et al. JOURNAL OF CONTROLLED RELEASE
- Cationic Liposomes Loaded with a Synthetic Long Peptide and Poly(I:C): a Defined Adjuvanted Vaccine for Induction of Antigen-Specific T Cell Cytotoxicity
- (2014) Eleni Maria Varypataki et al. AAPS Journal
- Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
- (2014) Zhenghong Xu et al. ACS Nano
- The activation of the adaptive immune system: Cross-talk between antigen-presenting cells, T cells and B cells
- (2014) Joke M.M. den Haan et al. IMMUNOLOGY LETTERS
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant
- (2014) Karen Smith Korsholm et al. VACCINE
- Tumor metastasis: moving new biological insights into the clinic
- (2013) Liling Wan et al. NATURE MEDICINE
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started